This thought-leadership document outlines five critical questions biotechs should ask to improve clinical trial success. Topics include selecting meaningful and regulatory-accepted endpoints, ensuring operational excellence, choosing the right CRO or endpoint partner, balancing participant centricity with scientific rigor, and de-risking study execution. The content emphasizes patient-centered outcomes, data quality, early regulatory engagement, and proactive risk management. Practical guidance is provided on protocol design, governance, real-time monitoring, and stakeholder alignment. Written by Clario medical and operational leaders, the document serves as a strategic framework to help emerging biotechs navigate complexity, avoid common pitfalls, and accelerate development with confidenc

Join for free to read